Security key
15117B103
- Security type / class
- Equity / COM
- Total 13F shares
- 84,927,625
- Total 13F value
- $320,985,942
- Share change
- -3,116,094
- Put/Call ratio
- 84%
- SEC-reported price per share
- $3.78
- Number of holders
- 137
- Value change
- -$74,271,269
- Number of buys
- 71
- Number of sells
- 90
Open additional details 1 more signal available
Report period
Q1 2016
Institutions
137
Top holders
0
CLDX full security history
Ownership snapshot
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CLDX - CELLDEX THERAPEUTICS INC NEW - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Archived quarter
Historical 13F summary for Q1 2016
This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.